Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin

BACKGROUND: The current stopping rule for peginterferon/ribavirin therapy in hepatitis C virus genotype-1 (HCV-1) patients is based on an early virological response (EVR, defined as >2 log(10) viral reduction at treatment week 12). We aimed to explore rapid stopping rules at week 4. METHODS: We r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yu, Ming-Lung, Liu, Chen-Hua, Huang, Chung-Feng, Tseng, Tai-Chung, Huang, Jee-Fu, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Kao, Jia-Horng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528729/
https://ncbi.nlm.nih.gov/pubmed/23284866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0052048
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak